BlackRock Institutional Trust’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$38.5M Buy
767,688
+15,412
+2% +$810K 0.01% 1510
2016
Q3
$39.5M Buy
752,276
+31,750
+4% +$1.52M 0.01% 1442
2016
Q2
$29.8M Buy
720,526
+128,131
+22% +$5.57M ﹤0.01% 1576
2016
Q1
$24.1M Sell
592,395
-21,681
-4% -$745K ﹤0.01% 1689
2015
Q4
$25.5M Sell
614,076
-28,000
-4% -$939K ﹤0.01% 1692
2015
Q3
$9.88M Buy
642,076
+133,454
+26% +$2.87M ﹤0.01% 2310
2015
Q2
$12.6M Buy
508,622
+75,346
+17% +$1.68M ﹤0.01% 2249
2015
Q1
$9.9M Buy
433,276
+164,846
+61% +$4.16M ﹤0.01% 2395
2014
Q4
$7.25M Buy
268,430
+105,851
+65% +$1.82M ﹤0.01% 2547
2014
Q3
$1.91M Sell
162,579
-86,090
-35% -$1.09M ﹤0.01% 3098
2014
Q2
$3.87M Buy
248,669
+8,144
+3% +$117K ﹤0.01% 2899
2014
Q1
$4.73M Buy
240,525
+153,048
+175% +$2.6M ﹤0.01% 2809
2013
Q4
$1.47M Buy
+87,477
New +$1.09M ﹤0.01% 3270

Other funds holding FPRX